Home › Funds › Forefront Analytics, LLC › BCYC

Forefront Analytics, LLC position in BCYC

BICYCLE THERAPEUTICS PLC · Health Care

Forefront Analytics, LLC reported holding 32,357 shares of BCYC (BICYCLE THERAPEUTICS PLC) in its Q3 2026 13F filing — a position valued at US$119K, representing 0.12% of its reported portfolio and ranking #35 among its reported holdings. Forefront Analytics, LLC has disclosed BCYC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)32.36K sh
Reported value held$119.07K
Portfolio Weight0.12%
First reportedQ4 2025
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Forefront Analytics, LLC's BCYC position evolved

Forefront Analytics, LLC first disclosed a stake in BCYC in Q4 2025 at 13,371 shares (US$95K). The position peaked in Q3 2026 at 32,357 shares, worth US$119K. Across 4 filings, Forefront Analytics, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 32,357 shares valued at US$119K — an increase of 10,535 shares quarter over quarter.. Notable position changes include a 52% increase in Q2 2026 (shares fell 13% over the following quarter), a 48% increase in Q3 2026 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 13.37K $94.67K New
Q1 2026 14.39K $66.79K Add
Q2 2026 21.82K $92.53K Add
Q3 2026 32.36K $119.07K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BCYC and 13F data

BCYC (BICYCLE THERAPEUTICS PLC) is a Health Care company. 10 other funds we track also report a position in BCYC — the largest reported positions include BAKER BROS. ADVISORS LP (US$46.2M), FCPM III SERVICES B.V. (US$14.7M), Long Focus Capital Management, LLC (US$14.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BCYC

All BCYC fund holders →

FAQ

How long has Forefront Analytics, LLC held BCYC?

Forefront Analytics, LLC has disclosed BCYC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Forefront Analytics, LLC's current position in BCYC?

As of Q3 2026, Forefront Analytics, LLC holds 32.36K shares of BCYC (BICYCLE THERAPEUTICS PLC), valued at $119.07K, representing 0.12% of its reported portfolio and ranking #35.

Has Forefront Analytics, LLC been buying or selling BCYC?

In the latest 13F filing (Q3 2026), Forefront Analytics, LLC increased its position in BCYC. The position peaked in Q3 2026 at 32.36K shares.

Which other funds hold BCYC?

Other major institutional holders of BCYC include BAKER BROS. ADVISORS LP, FCPM III SERVICES B.V., Long Focus Capital Management, LLC, among 10 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.